Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Alacacıoğlu, İ."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Esmeray Sönmez E; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye., Hatipoğlu T; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye., Kurşun D; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye., Hu X; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye., Akman B; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye., Yuan H; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Department of Basic Oncology, Oncology Institute, Dokuz Eylül University, İzmir 35340, Türkiye., Erşen Danyeli A; Department of Pathology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.; Department of Pathology, Acıbadem University Altunizade Hospital, İstanbul 34662, Türkiye., Alacacıoğlu İ; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye., Özkal S; Department of Pathology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye., Olgun A; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.; İzmir Tepecik Research and Training Hospital, Health Sciences University, İzmir 35020, Türkiye., Erdağ TK; Department of Otorhinolaryngology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye., You H; Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, Department of Hematology and Oncology, Children's Hospital of Chongqing Medical University, Chongqing 401122, China.; International Science and Technology Cooperation Base of Child Development and Critical Disorders, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing 401122, China., Küçük C; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye.; Department of Medical Biology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.
Publikováno v:
Cells [Cells] 2022 Oct 27; Vol. 11 (21). Date of Electronic Publication: 2022 Oct 27.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hatipoğlu T; İzmir Biomedicine and Genome Center, İzmir, Turkey.; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir, Turkey., Esmeray Sönmez E; İzmir Biomedicine and Genome Center, İzmir, Turkey.; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir, Turkey., Hu X; İzmir Biomedicine and Genome Center, İzmir, Turkey.; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir, Turkey., Yuan H; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir, Turkey., Danyeli AE; Department of Pathology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey., Şeyhanlı A; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey., Önal-Süzek T; Department of Bioinformatics, Graduate School of Natural and Applied Sciences, Muğla Sıtkı Koçman University, Muğla, Turkey., Zhang W; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, United States., Akman B; İzmir Biomedicine and Genome Center, İzmir, Turkey.; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir, Turkey., Olgun A; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey., Özkal S; Department of Pathology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey., Alacacıoğlu İ; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey., Özcan MA; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey., You H; Department of Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China., Küçük C; İzmir Biomedicine and Genome Center, İzmir, Turkey.; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir, Turkey.; Department of Medical Biology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Jun 16; Vol. 12, pp. 870487. Date of Electronic Publication: 2022 Jun 16 (Print Publication: 2022).
Autor:
Şeyhanlı A; Sivas Numune Hospital, Clinic of Hematology, Sivas, Turkey, Yavuz B; Dokuz Eylül University Faculty of Medicine, Department of Hematology, İzmir, Turkey, Akşit Z; Dokuz Eylül University Faculty of Medicine, Department of Internal Medicine, İzmir, Turkey, Yüce Z; Dokuz Eylül University Faculty of Medicine, Department of Medical Biology, İzmir, Turkey, Özkal S; Dokuz Eylül University Faculty of Medicine, Department of Pathology, İzmir, Turkey, Altungöz O; Dokuz Eylül University Faculty of Medicine, Department of Medical Biology, İzmir, Turkey, Demirkan F; Dokuz Eylül University Faculty of Medicine, Department of Hematology, İzmir, Turkey, Alacacıoğlu İ; Dokuz Eylül University Faculty of Medicine, Department of Hematology, İzmir, Turkey, Özsan GH; Dokuz Eylül University Faculty of Medicine, Department of Hematology, İzmir, Turkey
Publikováno v:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2022 Jun 01; Vol. 39 (2), pp. 109-116. Date of Electronic Publication: 2021 Nov 26.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
ÖZDEMİRKIRAN, F., SOLMAZ MEDENİ, Serife, ÖZDEMİRKIRAN, Füsun, Payzın, K. B., PAYZIN, Kadriye Bahriye, Sevindik, Ö. G., ACAR, C., SEVİNDİK, Ömür Gökmen, ACAR, Celal, TÜRKYILMAZ, D., TÜRKYILMAZ, Doğuş, Kaya, S. Yiğit, Alacacıoğlu, İ., KAYA, Süreyya Yiğit, Pişkin, Ö., ALACACIOĞLU, İnci, DEMİRKAN, F., PİŞKİN, Özden, ÖZSAN, H. G., DEMİRKAN, Fatih, ÖZSAN, Hayri Güner, Özcan, M. A., ÖZCAN, Mehmet Ali
Publikováno v:
Volume: 28, Issue: 3 139-143
Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi
Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi
Objective: Classically, chronic intravascular hemolysis, bone marrow failure, thrombosis in Paroxysmal Nocturnal Hemoglobinuria manifested (PNH) is a clonal disorder of hematopoietic stem cells. Eculizimab is a monoclonal antibody for the treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::bf6aa151a3a61fb20d781409edf223df
https://dergipark.org.tr/tr/pub/deutip/issue/4670/63591
https://dergipark.org.tr/tr/pub/deutip/issue/4670/63591
Autor:
Özdemirkıran F., Payzın B., Kiper H.D., Kabukçu S., Çağlıyan G.A., Kahraman S., Sevindik Ö.G., Ceylan C., Kadıköylü G., Şahin F., Keskin A., Arslan Ö., Özcan M.A., Görgün G., Bolaman Z., Büyükkeçeci F., Bilgir O., Alacacıoğlu İ., Vural F., Tombuloğlu M., Gökgöz Z., Saydam, G..
PubMed ID: 25914025
Objective: Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease of the platelet count to less than 100x109/L. Although it is included in a benign disease group, bleedin
Objective: Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease of the platelet count to less than 100x109/L. Although it is included in a benign disease group, bleedin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::a324de663e82f5c565e518399b7212f8
https://hdl.handle.net/11454/26071
https://hdl.handle.net/11454/26071